Global Peptide CDMO Pharmaceutical Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Peptide CDMO Pharmaceutical Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application
Peptide CDMO Pharmaceutical report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Peptide CDMO Pharmaceutical market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Peptide Supplements and Peptide Vaccines are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Peptide CDMO Pharmaceutical industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Peptide CDMO Pharmaceutical key companies include Ambiopharm, Auspep, Bachem, Bcn Peptide, Cpc Scientific, Creative Peptides, Chinese Peptide, Csbio and Corden Pharma, etc. Ambiopharm, Auspep, Bachem are top 3 players and held % share in total in 2022.
Peptide CDMO Pharmaceutical can be divided into Liquid-phase Peptide Synthesis（LPPS）, Solid-phase Peptide Synthesis（SPPS） and Mixed Phase,, etc. Liquid-phase Peptide Synthesis（LPPS） is the mainstream product in the market, accounting for % share globally in 2022.
Peptide CDMO Pharmaceutical is widely used in various fields, such as Peptide Supplements, Peptide Vaccines and Others,, etc. Peptide Supplements provides greatest supports to the Peptide CDMO Pharmaceutical industry development. In 2022, global % share of Peptide CDMO Pharmaceutical went into Peptide Supplements filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Peptide CDMO Pharmaceutical market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Ambiopharm
Auspep
Bachem
Bcn Peptide
Cpc Scientific
Creative Peptides
Chinese Peptide
Csbio
Corden Pharma
Polypeptide
Hybio Pharmaceutical
Peptide Institute
Pepscan
Almac
Vivitide
Creosalus Inc
Scinopharm
Senn Chemicals
Belyntic
Ferring Pharma
Numaferm
Hybio Pharmaceutical
Provepharm Life Solutions
Enzene Biosciences
Piramal Pharma
Segment by Type
Liquid-phase Peptide Synthesis（LPPS）
Solid-phase Peptide Synthesis（SPPS）
Mixed Phase
Peptide Supplements
Peptide Vaccines
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Peptide CDMO Pharmaceutical market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Peptide CDMO Pharmaceutical introduction, etc. Peptide CDMO Pharmaceutical Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Peptide CDMO Pharmaceutical market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
North America, Europe and Asia Pacific are the key regions for Peptide CDMO Pharmaceutical industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Peptide CDMO Pharmaceutical key companies include Ambiopharm, Auspep, Bachem, Bcn Peptide, Cpc Scientific, Creative Peptides, Chinese Peptide, Csbio and Corden Pharma, etc. Ambiopharm, Auspep, Bachem are top 3 players and held % share in total in 2022.
Peptide CDMO Pharmaceutical can be divided into Liquid-phase Peptide Synthesis（LPPS）, Solid-phase Peptide Synthesis（SPPS） and Mixed Phase,, etc. Liquid-phase Peptide Synthesis（LPPS） is the mainstream product in the market, accounting for % share globally in 2022.
Peptide CDMO Pharmaceutical is widely used in various fields, such as Peptide Supplements, Peptide Vaccines and Others,, etc. Peptide Supplements provides greatest supports to the Peptide CDMO Pharmaceutical industry development. In 2022, global % share of Peptide CDMO Pharmaceutical went into Peptide Supplements filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Peptide CDMO Pharmaceutical market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Ambiopharm
Auspep
Bachem
Bcn Peptide
Cpc Scientific
Creative Peptides
Chinese Peptide
Csbio
Corden Pharma
Polypeptide
Hybio Pharmaceutical
Peptide Institute
Pepscan
Almac
Vivitide
Creosalus Inc
Scinopharm
Senn Chemicals
Belyntic
Ferring Pharma
Numaferm
Hybio Pharmaceutical
Provepharm Life Solutions
Enzene Biosciences
Piramal Pharma
Segment by Type
Liquid-phase Peptide Synthesis（LPPS）
Solid-phase Peptide Synthesis（SPPS）
Mixed Phase
Segment by Application
Peptide Supplements
Peptide Vaccines
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Peptide CDMO Pharmaceutical market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Peptide CDMO Pharmaceutical introduction, etc. Peptide CDMO Pharmaceutical Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Peptide CDMO Pharmaceutical market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices